EQUILLIUM, INC. (EQ) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -18.01M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-18.01M | (m) |
| 2026-03-31 | (m) | $-19.05M | (m) |
| 2025-12-31 | (m) | $-22.40M | (m) |
| 2025-09-30 | (m) | $-24.42M | (m) |
| 2025-06-30 | (m) | $-20.19M | (m) |
| 2025-03-31 | (m) | $-13.99M | (m) |
| 2024-12-31 | (m) | $-8.07M | (m) |
| 2024-09-30 | (m) | $-4.62M | (m) |
| 2024-06-30 | (m) | $-8.32M | (m) |
| 2024-03-31 | (m) | $-12.13M | (m) |
| 2023-12-31 | (m) | $-13.34M | (m) |
| 2023-09-30 | (m) | $-8.22M | (m) |
| 2023-06-30 | (m) | $-18.16M | (m) |
| 2023-03-31 | (m) | $-28.95M | (m) |
| 2022-12-31 | (m) | $-62.43M | (m) |
| 2022-09-30 | (m) | $-75.82M | (m) |
| 2022-06-30 | (m) | $-72.45M | (m) |
| 2022-03-31 | (m) | $-67.48M | (m) |
| 2021-12-31 | (m) | $-39.05M | (m) |
| 2021-09-30 | (m) | $-37.35M | (m) |
| 2021-06-30 | (m) | $-33.66M | (m) |
| 2021-03-31 | (m) | $-30.97M | (m) |
| 2020-12-31 | (m) | $-29.81M | (m) |
| 2020-09-30 | (m) | $-28.46M | (m) |
| 2020-06-30 | (m) | $-27.88M | (m) |
| 2020-03-31 | (m) | $-27.49M | (m) |
| 2019-12-31 | (m) | $-25.60M | (m) |
| 2019-09-30 | (m) | $-23.02M | (m) |
| 2019-06-30 | (m) | $-21.93M | (m) |
| 2019-03-31 | (m) | $-17.62M | (m) |
| 2018-12-31 | (m) | $-13.25M | (m) |
| 2018-09-30 | (m) | (m) | (m) |
| 2018-06-30 | (m) | $-4.59M | (m) |
| 2018-03-31 | (m) | $-3.77M | (m) |
| 2017-12-31 | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |